Launched in 2006 by Bio2Business Ltd, the Biotech Outsourcing Strategies Events bring together stakeholders in R&D outsourcing to share experience, build existing outsourcing partnerships and forge new buyer/supplier business relationships. The established BOS Formula is built on 4 key pillars; Exhibition showcasing international CROs and CMOs; High Quality Content (delivered through the multi-stream programme); 1-to-1 Partnering; Informal Networking (BOS Events are known for being friendly, intimate events, which create the perfect conditions for networking!).
Since 2016 we are pleased to call Basel our home of our summer event (we run a sister event in Manchester, UK, in November 2020). Located in the heart of Europe, Basel is a unique Life Science Ecosystem which we are proud to support. BOS Basel 2020 will cover Discovery Outsourcing, Small Molecule CMC Outsourcing and Biologics CMC Outsourcing.
Working with CMOs to Develop a Robust Manufacturing Strategy for Recombinant Virus Vectors
Dr Catherine Cancian, VP Pharma Operations, Gensight Biologics
ABSTRACT: At GenSight Biologics, we have been working to accelerate cycle times and manage regulatory compliance from early development (preclinical to first- in- man) to commercial to provide to the patients beneficial solutions for counteracting the effect of rare and irreversible vision loss that can lead to legal blindness in very short time after the onset of the disease.
This presentation highlights the CMC strategy we have developed in the context of operational outsourcing to key suppliers including analytical, process development, manufacturing, and supply chain.
Dr Firelli Alonso, Senior Director, External Supply, BioTherapeutics & Vaccines Outsourcing, Pfizer, to present at BOS Basel 2020
Dr Firelli Alonso, Senior Director, External Supply, BioTherapeutics & Vaccines Outsourcing, Pfizer, will present in the Biologics CMC Outsourcing work-stream at BOS Basel 2020. Her confirmed presentation title is "Agile sourcing strategies for new therapeutic modalities".
CALIXAR confirms Silver Sponsorship at BOS Basel 2020
Bio2Business is delighted to welcome CALIXAR as a SILVER Sponsor at BOS Basel 2020. CALIXAR has developed unique technologies coupled with a state-of-the-art research platform enabling the production of novel therapeutic targets of the highest quality and covering all therapeutic areas. In particular, CALIXAR uses its patented technology platform for other companies that need to identify, express, extract, purify and stabilize native membrane proteins (GPCRs, ion channels, receptors, transporters and viral targets).
Legacy Pharmaceuticals Switzerland GmbH Confirms Gold Sponsor Package in partnership with SCHOTT Pharmaceutical Systems at BOS Basel 2020
Legacy Pharmaceuticals, a global GMP-compliant contract manufacturer of sterile/aseptic in liquid and powder form and non-sterile semi-solid pharmaceutical products was founded in 1947. The company remains true to its Swiss origins and has built up a justified reputation for excellence, quality and reliability in the industry. FDA approved and globally active, the products Legacy manufacture on behalf of third parties are sold in 112 countries around the world including Japan, Russia, Korea to name a few.